Regardless of these legal guidelines, manufacturers have continued to tweak the chemical formulation to generate new variations of artificial cannabinoids that are not protected by existing laws.These modifications could account for many of the neurological and behavioral signs or symptoms that extensive-time period inhalant users exhibit, such as